VJHemOnc is committed to improving our service to you

EBMT-EHA CAR-T 2019 | CAR T-cell therapy for solid cancers

VJHemOnc is committed to improving our service to you

Jürgen Kuball

Jürgen Kuball MD, PhD, from the University Medical Center, Utrecht, Amsterdam, discusses the potential for CART-cell therapy in solid cancers, as well as the challenges involved in transitioning a treatment designed for hematological cancers to other forms of tumour-based cancers. Recorded at the 1st European CAR T-cell meeting in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter